Qpex Biopharma, Inc. is a biopharmaceutical company located in San Diego, California, specializing in infectious disease solutions as part of the Shionogi Group.
Subscribe to see Qpex Biopharma, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Qpex Biopharma, Inc. is a biotechnology company headquartered in San Diego, United States. Its most recent funding round raised $27.4M in October 2018. Xcout tracks 6 named people at Qpex Biopharma, Inc., including Gareth Morgan (President).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $27.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Qpex Biopharma, Inc.'s closest competitors — see the full list of competitors and alternatives →
KinoPharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Tokyo, Japan. The company focuses on researching and developing innovative small-molecule drugs based on novel concepts to address major medical needs, such as antiviral treatments.
Soteria Biotherapeutics, Inc. is a biopharmaceutical company founded in 2018 and headquartered in San Francisco, California, specializing in biopharmaceutical advancements and drug pipelines.
C3J Therapeutics, Inc. is a clinical-stage biotechnology company based in Los Angeles, California, focused on improving human health through the development of targeted antimicrobials.
Omnix Medical is a biopharmaceutical company that develops novel antibiotic agents and antimicrobial peptides to treat infections caused by drug-resistant bacteria. The company focuses on creating first-in-its-class anti-infective therapeutics, such as its lead compound OMN6, to target life-threatening bacterial strains.
Alopexx, Inc. is a U.S. biotechnology company developing broad-spectrum anti-infective vaccines and antibody-based therapies. Its programs target PNAG, a surface polysaccharide found on many bacterial and fungal pathogens, for potential treatment or prevention of serious infections.
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Carlsbad, California. The company focuses on the development of novel oral antiviral treatments for viral diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Qpex Biopharma, Inc.? Suggest a correction · Work at Qpex Biopharma, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.